Bioactivity | 9-Hydroxyoctadecanoic acid (9-HSA) is an HDAC1 inhibitor that inhibits ∼66.4% HDAC1 enzymatic activity at 5 μM. 9-Hydroxyoctadecanoic acid shows anticancer activity[1]. | ||||||||||||
Invitro | 9-Hydroxyoctadecanoic acid (9-HSA) 可以结合到人 HDAC1 蛋白三维模型的活性位点[1]。9-Hydroxyoctadecanoic acid (9-HSA) (100 μM; 24 h) 抑制 HT29 细胞增殖,诱导 G0/G1 阻滞,并在转录和翻译水平上增加 p21WAF1 表达[2]。 Cell Proliferation Assay9-Hydroxyoctadecanoic acid 可以结合到人 HDAC1 蛋白三维模型的活性位点[1]。 Cell Line: | ||||||||||||
Name | 9-Hydroxyoctadecanoic acid | ||||||||||||
CAS | 3384-24-5 | ||||||||||||
Formula | C18H36O3 | ||||||||||||
Molar Mass | 300.48 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Calonghi N, et al. Histone deacetylase 1: a target of 9-hydroxystearic acid in the inhibition of cell growth in human colon cancer. J Lipid Res. 2005 Aug;46(8):1596-603. [2]. Calonghi N, et al. 9-Hydroxystearic acid upregulates p21(WAF1) in HT29 cancer cells. Biochem Biophys Res Commun. 2004 Jan 30;314(1):138-42. |